Managing childhood sellar and suprasellar tumors requires a delicate balance between local oncological eradication and the preservation of critical neurocognitive, optical, and hormonal structures. The clinical adoption of pediatric craniopharyngioma radiosurgery has evolved as a targeted alternative to radical resection and broad-field fractionated radiotherapy. Because craniopharyngiomas frequently abut the optic apparatus and hypothalamic-pituitary axis, radical surgery carries substantial risks of hypothalamic obesity, visual deficits, and panhypopituitarism. Meanwhile, conventional fractionated radiation delivers dispersed radiation doses that can damage developing brain tissue. Stereotactic radiosurgery offers steep dose gradients that deliver concentrated radiation to the lesion while sparing adjacent neural pathways. Consequently, clinicians increasingly favor this precise modality to manage recurrent or residual pediatric craniopharyngiomas.

Pediatric Craniopharyngioma Radiosurgery: Clinical Rationale and Multicenter Study Design

A collaborative multicenter retrospective investigation evaluated the definitive therapeutic value and safety of Gamma Knife radiosurgery in pediatric craniopharyngioma management. Specifically, investigators analyzed 33 consecutive pediatric patients aged under 18 years treated across two high-volume neurosurgical centers. These children underwent radiosurgical intervention specifically for residual or progressively recurrent craniopharyngiomas following initial surgical debulking. The mean age at the time of radiosurgery was 11.8 years, and the treated cohort presented with a mean baseline tumor volume of 2.3 cm³. Furthermore, the investigators gathered longitudinal follow-up data spanning a median of 122.8 months, providing critical insights over a ten-year observation window. By standardizing patient selection and treatment protocols across centers, the study established high-resolution evidence regarding radiosurgical efficacy. The authors addressed critical questions regarding long-term recurrence rates, late neurological deficits, and durable functional preservation in young individuals.

Tumor Volume Control and Long-Term Recurrence-Free Survival

The primary endpoint evaluated across the cohort was radiographic tumor control within and around the radiosurgical target volume. Radiosurgical treatment achieved solid disease stability, demonstrating actuarial recurrence-free survival rates of 84.8% at 1 year, 78.6% at 3 years, and 67.7% at 5 years. Moreover, at the 10-year post-treatment mark, recurrence-free survival remained durable at 48.6%. Considering the complex nature and high intrinsic relapse potential of childhood craniopharyngiomas, these outcomes highlight robust local disease containment. The stereotactic approach successfully arrested solid tumor progression in a substantial majority of patients during their crucial developmental years. Additionally, clinicians noted that maintaining marginal target doses above therapeutic thresholds yielded sustained growth suppression. Therefore, radiosurgery establishes long-lasting volumetric control, reducing the frequent requirement for morbid repeated open craniotomies in young patients.

In-Field Stability Versus Out-of-Field Tumor Progression Patterns

A crucial insight from this multicenter cohort relates to the anatomic spatial pattern and temporal latency of tumor recurrence. When disease progression occurred, 66.7% of recurrences developed outside the original irradiated treatment volume. In sharp contrast, in-field failures occurred much less frequently. Furthermore, in-field recurrences exhibited a significantly longer latency period compared to out-of-field failures, emerging at 63.9 months versus 19.6 months. Consequently, these findings confirm that stereotactic beams reliably ablate targeted tissue with durable precision. However, cyst dynamics and microscopic cell migration along anatomical planes outside the radiation margin explain out-of-field expansions. Clinicians must therefore understand that radiosurgery secures the targeted focus, but surveillance protocols must vigilantly screen distant suprasellar regions. Routine high-resolution magnetic resonance imaging remains essential to detect peripheral or cystic changes before symptoms manifest.

Preservation of Visual Acuity and Functional Neurological Outcomes

Protecting the anterior visual pathway represents a paramount priority when designing sellar radiation treatment plans. Children are especially vulnerable to radiation-induced optic neuropathy, which can permanently impair development and independence. In this study, visual function remained stable or improved in 97% of treated children throughout the longitudinal follow-up. Only one single patient suffered visual deterioration, and progressive tumor compression caused this deficit rather than radiation toxicity. Thus, keeping radiation doses to the optic chiasm and optic nerves within validated safety parameters successfully prevented secondary visual decline. Furthermore, children maintained their baseline functional performance without suffering treatment-induced cognitive regression or radiation-induced vasculopathy. By sharply confining high therapeutic doses to the lesion, pediatric craniopharyngioma radiosurgery delivers favorable functional neuroprotection compared with older comprehensive radiotherapy modalities.

Endocrinological Morbidity and Pituitary Axis Preservation

Hypothalamic and pituitary damage remains a common late complication following childhood brain tumor interventions, predisposing children to severe hormonal deficiencies. In this retrospective series, new-onset endocrinological deficits occurred uncommonly after Gamma Knife treatment. Remarkably, newly acquired anterior or posterior pituitary deficits developed exclusively in children with pre-existing partial hypopituitarism. Among patients with pre-existing hormonal deficits, 22.2% developed additional endocrinopathies during follow-up, whereas none of the patients with normal baseline endocrine function suffered hormone loss. Consequently, this striking statistical difference underscores the vulnerability of previously damaged pituitary tissue. Conversely, intact endocrine structures demonstrate substantial resilience against steep fall-off radiosurgical fields. Clinicians should reassure families that upfront functional pituitary tissue rarely sustains de novo injury when margins are planned meticulously.

Translating Radiosurgical Evidence into Multidisciplinary Pediatric Practice

Integrating these long-term findings into neuro-oncological pathways requires close coordination among pediatric endocrinologists, neurosurgeons, and radiation oncologists. In modern practice, conservative subtotal surgical resection followed by stereotactic radiosurgery represents an effective strategy to avoid hypothalamic injury. Instead of pursuing aggressive, hazardous complete resections, surgeons can safely leave residual fragments adjacent to the chiasm for targeted irradiation. Furthermore, because two-thirds of late failures occur outside the field, multidisciplinary teams must implement structured neuroimaging schedules. Clinicians should combine neuro-ophthalmic assessments and dynamic endocrine screening during follow-up visits. Additionally, emerging molecular characterizations, such as identifying BRAF mutations in papillary subtypes, offer opportunities to combine targeted systemic therapies with focal radiosurgical delivery. Ultimately, precision radiosurgery preserves vital developmental potential while securing long-term tumor arrest.

Frequently Asked Questions

How does stereotactic radiosurgery compare with conventional radiotherapy for pediatric craniopharyngioma?

Stereotactic radiosurgery delivers conformal, concentrated radiation doses with rapid dose fall-off, minimizing exposure to normal brain tissue. In contrast, conventional fractionated radiotherapy irradiates broader cerebral fields, which significantly increases long-term risks of neurocognitive impairment, vascular injury, and hypothalamic obesity in growing children.

What is the risk of visual impairment following stereotactic radiosurgery in children?

The risk of treatment-induced visual decline is exceptionally low when radiation doses to the optic chiasm remain within established safety thresholds. In clinical studies, visual function remained stable or improved in 97% of pediatric patients, with visual loss occurring almost exclusively from secondary tumor progression rather than radiation injury.

Why do recurrences typically occur outside the irradiated margin rather than within the target field?

Radiosurgery reliably ablates solid tissue within the targeted field, resulting in prolonged in-field stability. However, craniopharyngiomas frequently harbor microscopic extensions or expanding fluid-filled cysts along anatomical planes. These peripheral components can proliferate outside original margin volumes, producing out-of-field relapses that require ongoing MRI surveillance.

Disclaimer: This content is for informational and educational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or treatment procedure. Never disregard professional medical advice or delay in seeking it because of something you have read here. Refer to the latest local and national guidelines for clinical practice.

References

1. Albano L et al. Stereotactic radiosurgery for pediatric craniopharyngiomas: a multicenter retrospective study. J Neurooncol. 2026 May 12. doi: 10.1007/s11060-026-05595-3. PMID: 42118226.


2. Murphy ES, Sahgal A, Regis J, Levivier M, Fariselli L, Gorgulho A, et al. Pediatric cranial stereotactic radiosurgery: Meta-analysis and international stereotactic radiosurgery society practice guidelines. Neuro Oncol. 2025 Feb 10;27(2):517-532.


3. Buwaider A, Kananathan M, Tabari S, Hylin S, Lippitz B, Úlfarsson E, et al. Long-Term Outcomes After Gamma Knife Radiosurgery Treatment of Craniopharyngiomas: A Swedish Nationwide Cohort With a Mean Follow-Up of 21 Years. Neurosurgery. 2025;97(3):657–670.